FDA declines to approve Allergan's Esmya
August 21, 2018 at 17:16 PM EDT
Allergan Plc said on Tuesday U.S. health regulators had declined to approve Esmya, its treatment for abnormal uterine bleeding in women with uterine fibroids, requesting more information and citing safety issues outside the United States.